Literature DB >> 2474896

Identification of PR8 M1 protein in influenza virus high-yield reassortants by M1-specific monoclonal antibodies.

B E Johansson1, D J Bucher, B A Pokorny, A Mikhail, E D Kilbourne.   

Abstract

A panel of monoclonal antibodies to the M1 protein of A/PR8/34 (H1N1) (PR8) influenza A virus was found to distinguish in ELISA high-yielding reassortant viruses derived from reassortment of PR8 and X-31 (H3N2) viruses with recently prevalent field strains of H1N1 or H3N2 subtype. These findings are concordant with results of genotyping that demonstrated the presence of PR8 RNA 7 or M1 protein in high-yield reassortants by RNA or protein PAGE. All high-yield vaccine candidate reassortants Application of the M1 monoclonal antibody panel facilitates the isolation of high-yield vaccine candidate reassortants bearing the PR8 M1 gene, and should aid in epidemiologic strain tracking as well.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474896     DOI: 10.1016/0042-6822(89)90638-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  Virulence of influenza A virus for mouse lung.

Authors:  A C Ward
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8.

Authors:  E G Brown
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth.

Authors:  C A Smeenk; E G Brown
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

Review 4.  Current Opinion in LAIV: A Matter of Parent Virus Choice.

Authors:  Irina Kiseleva
Journal:  Int J Mol Sci       Date:  2022-06-19       Impact factor: 6.208

5.  M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies.

Authors:  D Bucher; S Popple; M Baer; A Mikhail; Y F Gong; C Whitaker; E Paoletti; A Judd
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

6.  Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus.

Authors:  Chia-Ying Wu; Yi-Chun Yeh; Yu-Chih Yang; Ching Chou; Ming-Tsan Liu; Ho-Sheng Wu; Jia-Tsrong Chan; Pei-Wen Hsiao
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

7.  Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins.

Authors:  E D Kilbourne; B E Johansson; B Grajower
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

8.  Gene constellation of influenza A virus reassortants with high growth phenotype prepared as seed candidates for vaccine production.

Authors:  Andrew A Fulvini; Manojkumar Ramanunninair; Jianhua Le; Barbara A Pokorny; Jennifer Minieri Arroyo; Jeanmarie Silverman; Rene Devis; Doris Bucher
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

9.  Production of H5N1 Influenza Virus Matrix Protein 2 Ectodomain Protein Bodies in Tobacco Plants and in Insect Cells as a Candidate Universal Influenza Vaccine.

Authors:  Sandiswa Mbewana; Elizabeth Mortimer; Francisco F P G Pêra; Inga Isabel Hitzeroth; Edward P Rybicki
Journal:  Front Bioeng Biotechnol       Date:  2015-12-08

10.  Maintaining pH-dependent conformational flexibility of M1 is critical for efficient influenza A virus replication.

Authors:  Meng-Jung Chiang; Faik N Musayev; Martina Kosikova; Zhengshi Lin; Yamei Gao; Philip D Mosier; Bashayer Althufairi; Zhiping Ye; Qibing Zhou; Umesh R Desai; Hang Xie; Martin K Safo
Journal:  Emerg Microbes Infect       Date:  2017-12-06       Impact factor: 7.163

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.